Mobile phone related articles are
Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Endpoints | Frequency range | SAR | Exposure duration | Parameters |
---|---|---|---|---|---|---|---|
Liu YX et al. | 2015 | intact cell/cell culture, U251-MG, U87-MG, T98G and A127 (human glioblastoma cell lines) | cellular parameters <i>in vitro</i> and tumorigenesis <i>in vivo</i> | 1,950 MHz | 5 W/kg | continuous for 12 hours | mobile phone, CDMA, mobile communications |
Mansourian M et al. | 2020 | intact cell/cell culture, animal, mouse/BALB/c | - | 217 Hz–5 kHz | - | - | GSM, mobile communications, magnetic field, electric current application, low frequency, signals/pulses, intermediate frequency, co-exposure, also other exposures without EMF |
Mansourian M et al. | 2021 | intact cell/cell culture, 4T1 (mouse mammary tumour cells), animal, mouse/BALB/c | - | 5 kHz–900 MHz | - | - | mobile communications, mobile phone, GSM, electric current application, intermediate frequency, signals/pulses, also other exposures without EMF, co-exposure |
Mansourian M et al. | 2022 | animal, mouse/BALB/c | - | 5 kHz–900 MHz | - | - | mobile phone, GSM, mobile communications, electric current application, electrotherapy, intermediate frequency, also other exposures without EMF, co-exposure |
Oberto G et al. | 2007 | animal, mouse/PIM (transgenic mouse carrying the <i>pim</i>-1 oncogene) and wild-type C57BL6 mouse, whole body | tumor (lymphoma) incidence | 900 MHz | 0.5–4 W/kg | repeated daily exposure, 1 h/day, for 18 months | mobile phone, mobile communications |
Ouadah NS et al. | 2018 | animal, rat/Wistar, partial body | - | 900 MHz | - | - | GSM, mobile communications |
Repacholi MH et al. | 1997 | animal, mouse/Eµ-<i>Pim1</i><!--Eµ-Pim1--> transgenic (ppG64) and nontransgenic C57BL/6NTac, whole body | lymphoma | 900 MHz | 1.4–4.2 W/kg | repeated daily exposure for 30 min every 12 h for up to 18 months | GSM, mobile communications |
Salford L et al. | 1997 | animal, rat/Fischer 344; brains were infected with specific rat tumor cells (RG2 and N32 cells), whole body | brain tumor | 915 MHz | 0.0077–1.67 W/kg | repeated daily exposure, 7 h/day, 5 days/week, for 10-15 days | GSM, mobile communications, microwaves |
Salford LG et al. | 1993 | animal, rat/Fischer 344 | brain tumor | 915 MHz | 0.0077–1.67 W/kg | repeated daily exposure, 7 h/day, 5 days/week, for 10-15 days | GSM, mobile communications, microwaves |
Saran A et al. | 2007 | animal, mouse/<i>Patched1</i> (heterozygous knockout mouse) and wild type, whole body | carcinogenesis and tumor promotion | 900 MHz | 0.4 W/kg | 0.5 h/twice a day for 5 days (from day 2 to day 6 after birth) with a 6 h intervall between exposures | digital mobile phone, GSM, mobile communications |
Shirai T et al. | 2005 | animal, rat/Fischer 344, partial body: head | brain and spinal cord tumors | 1.439 GHz | 0.4–6 W/kg | repeated daily exposure, 90 min/day, 5 days/week for 104 weeks | PDC, TDMA, mobile communications |
Shirai T et al. | 2007 | animal, rat/Fischer 344, partial body: nose/head | tumor development in the central nervous system | 1.95 GHz | 0.464–7.6 W/kg | repeated daily exposure, 90 min/day, 5 days/week, for 104 weeks, starting at 5 weeks of age | digital mobile phone, CDMA, mobile communications |
Smith P et al. | 2007 | animal, rat/Han Wistar (HanBrl:WIST), whole body | carcinogenicity | 902 MHz | 0.41–4 W/kg | repeated daily exposure, 2 h/day, 5 days/week, for 52 or 104 weeks | digital mobile phone, GSM, mobile communications |
Sommer AM et al. | 2004 | animal, mouse/AKR/J, whole body | lymphoma | 900 MHz | 0.4 W/kg | continuous for about 40 weeks | GSM, mobile communications |
Sommer AM et al. | 2007 | animal, mouse/AKR/J, whole body | lymphoma development | 1.966 GHz | 0.4 W/kg | almost continuous for up to 248 days | digital mobile phone, UMTS, mobile communications |
Tillmann T et al. | 2007 | animal, mouse/B6C3F1 | carcinogenic effect | 902–1,747 MHz | 0.4–33.2 mW/g | repeated daily exposure, 2 h/day, 5 days/week, for 2 years | GSM, mobile communications |
Tillmann T et al. | 2010 | animal, mouse/B6C3F1, whole body | neoplasms and pre-neoplastic lesions and tumour incidences in spleen, kidneys, liver, lung, lymph nodes, and brain | 1,966 MHz | 0.62–5.76 W/kg | continuous for 20 hr/day, 7 days/week for up to 24 months | UMTS, mobile communications |
Utteridge TD et al. | 2002 | animal, mouse/Eµ-<i>Pim1</i><!--Eµ-Pim1--> (transgenic, C57BL/6Ntac) and the wild type of that strain, whole body | lymphoma | 898.4 MHz | 0.25–4 W/kg | repeated daily exposure for 1 h/day, 5 days/week for up to 104 weeks | GSM, mobile communications, microwaves |
Yang L et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts) | neoplastic promotion: cell morphology and cell proliferation <i>in vitro</i>; cancer promoting activity <i>in vivo</i> | 916 MHz | - | continuous for 2 h/day every day, until cells lost their contact inhibition (up to 8 weeks) | mobile phone, mobile communications, microwaves, CW continuous wave |
Yu D et al. | 2006 | animal, rat/Sprague-Dawley, whole body | mammary tumors | 900 MHz | 0.44–4 W/kg | repeated daily exposure, 4 h/day, 5 days/week, for 26 weeks | GSM, mobile communications, microwaves |
Zook BC et al. | 2001 | animal, rat/Sprague-Dawley, partial body: head, nose | brain and spinal cord tumors | 860 MHz | 0.42–1 W/kg | repeated daily exposure, 6 h/day, 5 days/week, from 2 up to 24 months of age | mobile communications, mobile phone |
Zook BC et al. | 2006 | animal, rat/Sprague-Dawley, partial body: head, nose | brain and spinal cord tumors (spinal nerve, spinal cord, cranial nerve, and brain tumors) | 860 MHz | 0.42–1 W/kg | repeated daily exposure, 6 h/day, 5 days/week, from 52 ± 2 days of age until scheduled killing at 30-day intervals between 171 and 325 days of age | digital mobile phone, mobile communications |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.